Chp, a homologue of the GTPase Cdc42Hs, activates the JNK pathway and is implicated in reorganizing the actin cytoskeleton  by Aronheim, Ami et al.
Brief Communication 1125
Chp, a homologue of the GTPase Cdc42Hs, activates the JNK
pathway and is implicated in reorganizing the actin cytoskeleton
Ami Aronheim*, Yehoshua C. Broder*, Aviva Cohen*, Alexandra Fritsch†,
Barbara Belisle† and Arie Abo†
The p21-activated protein kinases (PAKs) are
activated through direct interaction with the GTPases
Rac and Cdc42Hs, which are implicated in the control
of the mitogen-activated protein kinase (MAP kinase)
c-Jun N-terminal kinase (JNK) and the reorganization
of the actin cytoskeleton [1–3]. The exact role of the
PAK proteins in these signaling pathways is not
entirely clear. To elucidate the biological function of
Pak2 and to identify its molecular targets, we used a
novel two-hybrid system, the Ras recruitment system
(RRS), that aims to detect protein–protein
interactions at the inner surface of the plasma
membrane (described in the accompanying paper by
Broder et al. [4]). The Pak2 regulatory domain (PakR)
was fused at the carboxyl terminus of a RasL61
mutant protein and screened against a myristoylated
rat pituitary cDNA library. Four clones were identified
that interact specifically with PakR and three were
subsequently shown to encode a previously unknown
homologue of the GTPase Cdc42Hs. This ~36 kDa
protein, designated Chp, exhibits an overall sequence
identity to Cdc42Hs of ~52%. Chp contains two
additional sequences at the amino and carboxyl
termini that are not found in any known GTPase. The
amino terminus contains a polyproline sequence,
typically found in Src homology 3 (SH3)-binding
domains, and the carboxyl terminus appears to be
important for Pak2 binding. Results from the
microinjection of Chp into cells implicated Chp in the
induction of lamellipodia and showed that Chp
activates the JNK MAP kinase cascade.
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Results and discussion
Isolation of a Cdc42Hs homologue that interacts
specifically with Pak65
To identify proteins that interact with Pak65, we used a
modified form of the Sos recruitment system (SRS) [4,5].
The Pak2 regulatory domain (PakR) was fused to the car-
boxyl terminus of RasL61 devoid of its membrane attach-
ment signals (Ras(L61)∆F–PakR) and used to cotransform
cdc25-2 cells with a pituitary cDNA library containing the
v-Src myristoylation sequence as previously described [5].
Five galactose-dependent clones were isolated and the
specificity of the interaction examined. Clones #1, #2, #5
and #6 were able to grow at 36°C when cotransformed
with Ras(L61)∆F–PakR bait but not with the nonspecific
bait Ras(61)∆F–JDP2, suggesting that the interaction is
dependent on the PakR bait (Figure 1a). In contrast, clone
#8 grew at 36°C when cotransformed with either bait and
was subsequently shown to encode a Sos homologue —
Sos is an acknowledged false positive in this assay [4]
because when targeted to the membrane it is able to acti-
vate the yeast Ras by itself and confer growth at the
restrictive temperature. Clones #1, #2 and #5 were identi-
cal and exhibited sequence homology to the GTPases
Cdc42Hs and Rac1 (Figure 1b). As this cDNA appeared
independently three times in our screen, we focused
further analysis on this clone; the characterization of clone
#6 will be described elsewhere. 
DNA from clones #1, #2 and #5 was predicted to encode a
~36 kDa protein, designated Chp (for Cdc42Hs homo-
logue protein), with ~52% amino acid sequence identity to
Cdc42Hs. In addition to the homology to Cdc42Hs, Chp
contains sequences at the amino and carboxyl termini that
are not related to Cdc42Hs. An additional 28 amino acids
were found at the amino terminus of Chp that are absent
in Cdc42Hs, containing polyproline sequences typical of
SH3-binding regions. The carboxyl terminus of Chp does
not contain the classical CAAX box that is conserved
among all Ras-related GTPases [6]. Instead, Chp contains
an additional 32 amino acid sequence that does not share
sequence homology to known proteins in the database.
Chp transcription
To determine the tissue distribution of Chp, we used a
specific probe corresponding to the GTPase domain of
Chp (amino acids 102–151) in northern blot analysis of
mRNA from multiple rat tissues. This region exhibits only
62% identity with other members of the GTPase family. A
single mRNA species of about 1.5 kb was detected at high
levels in brain and testes; lower amounts were also
detected in spleen and lung tissues (Figure 1c). Interest-
ingly, small mRNAs (1.0 kb and 1.4 kb) have been
reported for other Rac-related proteins [6]. Hybridization
with probes corresponding to the amino and carboxyl
termini as well as full-length Chp gave similar results (data
not shown).
Chp expression
For protein analyses of Chp, polyclonal antibodies were
generated against a peptide corresponding to a unique
region at the carboxyl terminus of Chp. To compare the
size of endogenous Chp with that encoded by the cloned
cDNA, we fused the Chp cDNA to a sequence encoding a
Myc epitope tag and used this plasmid to overexpress
Myc–Chp in 293 cells. Whole-cell extracts derived from
either transfected or nontransfected 293 cells were sepa-
rated on SDS–PAGE and subjected to western blotting
with anti-Myc antibodies (Figure 1d, left panel). The
nitrocellulose filter was subsequently incubated with
affinity-purified anti-Chp antibodies (Figure 1d, right
panel) to show that the transfected Chp was identical in
size to the protein detected in nontransfected 293 cells
using the anti-Chp antibody.
Pak65 interacts with the activated Chp mutant
PakR interacts with the activated forms of Rac and Cdc42
[7–10]. On the basis of its sequence homology to Cdc42
and other Rho GTPases, we generated various Chp
mutants that are expected to differ in their GDP/GTP-
bound state. To make a constitutively active Chp, we sub-
stituted glycine 40 with valine (G40V). The equivalent
substitution in Rac and Cdc42Hs (G12V) results in an
active allele that is defective in GTPase hydrolysis. In
addition, we substituted amino acid 45 with asparagine.
Substitution of the corresponding amino acid (at position
17) to aspargine in other Rho GTPases results in a domi-
nant-negative allele that is locked in the GDP-bound
inactive form [11]. A cdc25-2 yeast strain was cotransfected
with plasmids encoding different Chp mutants fused to
myristoylation sequences together with Ras(61)∆F–PakR
bait. As presented in Figure 2a, constitutively active Chp
(Chp Ac) and wild-type Chp, but not the dominant-nega-
tive form of Chp (Chp Dn), interacted with PakR. 
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Figure 1
(a) Isolation using the RRS system of a novel protein that interacts
with the Pak2 regulatory domain. Ras(61)∆F–PakR bait was used to
screen a rat pituitary cDNA library in a temperature-sensitive cdc25
yeast strain. Five clones grew efficiently at 36°C only on a medium
containing galactose (the conditions under which library expression
was induced). Plasmid DNAs were isolated and re-introduced into the
same yeast strain with either the specific bait Ras(61)∆F–PakR or
nonspecific bait Ras(61)∆F–JDP2. Four of the clones — #1, #2, #5
and #6 — grew at 36°C with only the specific bait. (b) Amino acid
sequence alignment of Chp, Cdc42Hs and Rac1; Cdc42Hs and Rac1
sequences were retrieved from the NCBI Entrez database (accession
numbers P25763 and 131807 respectively) and the sequences were
aligned with Chp using the Laser Gene program. Grey shading
indicates residues that are identical in at least two members of the
group. (c) Tissue distribution of Chp. A northern blot (Clontech Inc.) of
RNA from multiple tissues was probed with either the Chp GTPase
domain or β-actin DNA fragments. Probing and washing were
performed according to the manufacturer’s protocols as described in
the Supplementary material. The washed filter was exposed to
autoradiography for 24 hr. (d) Western blot analysis with transfected
and nontransfected (mock) cell lines. Chp was transfected into 293
cells with a plasmid encoding Myc-epitope-tagged Chp (Myc–Chp).
Whole-cell extracts (50 µg/lane) from transfected and nontransfected
cells were separated by SDS–PAGE and blotted onto nitrocellulose.
Filters were probed with either anti-Myc or affinity-purified Chp
antisera. Size markers in kb (c) or kDa (d) are shown to the left.
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Similarly, constitutively active and wild-type Cdc42Hs,
but not the dominant-negative form, interact with PakR.
The expression levels of the different mutants were
similar (data not shown). These data suggest that the spe-
cific interaction between Chp and PakR is dependent on
the activation state of the GTPase.
The role of the Chp carboxy-terminal region for Pak65
binding
To investigate the role of the Chp amino-terminal and
carboxy-terminal sequences, we further mutated Chp Ac
by deletion of the carboxyl or amino terminus, or both.
Chp devoid of its carboxy-terminal domain was unable to
bind PakR in the two-hybrid system, whereas deletion of
the amino terminus had no significant effect on PakR
binding (Figure 2b). A similar result was obtained using
an overlay assay. Recombinant wild-type Chp was not 
efficiently loaded with [γ-32P]GTP (data not shown) 
and as a result the interaction with Pak2 or the
Wiskott–Aldrich syndrome protein (WASP) could not be
detected. In contrast, a Chp∆N mutant that was effi-
ciently loaded with [γ-32P]GTP exhibited strong interac-
tion with Pak2 and WASP (Figure 2c). Further, deletion
of the carboxyl terminus abrograted this interaction with
Pak2 and WASP (Figure 2c) despite normal binding to 
[γ-32P]GTP (data not shown). This result suggests that
the extended carboxyl terminus is either involved
directly in binding PakR or the loss of this domain
results in a conformational change in Chp that prevents
PakR binding.
Chp selectively activates the JNK MAP kinase pathway
To test whether Chp has a similar effect to Rac and Cdc42
[11,12] on the JNK cascade, we cotransfected 293 cells
with various mutants of Chp together with haemagglu-
tinin (HA)-tagged JNK2, extracellular-signal-regulated
kinase 2 (Erk2) or p38. Both wild-type and activated forms
of Chp stimulated the JNK kinase (Figure 3a). In contrast,
the dominant-negative form of Chp did not activate the
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Figure 2
Interaction of Pak65 with different Cdc42 and Chp mutants. Yeast
temperature-sensitive cdc25-2 cells were transformed with the
indicated plasmids and plated on glucose minimal medium
supplemented with the appropriate amino acids and bases. Four
independent transformants were grown at the permissive temperature,
24°C, replica plated onto appropriately supplemented galactose
minimal plates and grown at the restrictive temperature, 36°C.
Constructs used are described in the Supplementary material.
(a) PakR interacts with wild-type (Wt) Cdc42 and Chp and
constitutively activated (Ac) Cdc42-L61 and Chp-V40 but not
dominant-negative (Dn) Cdc42-N17 and Chp-N45. (b) PakR
interaction with Chp deletion mutants. Plasmids encoding dominant-
negative (Dn) Chp and activated (Ac) Chp or Chp Ac mutants lacking
either the amino terminus (∆N) or carboxyl terminus (∆C), or both, were
cotransfected into cdc25-2 cells together with Ras(61)∆F–PakR.
(c) Recombinant Pak2 and WASP (2–3 µg) were analyzed by the
overlay assay and probed with the indicated Chp mutants preloaded
with [γ-32P]GTP, as described in the Supplementary material. 
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Figure 3
(a) Activation of JNK by Chp. 293 cells were
cotransfected with plasmids encoding HA-
tagged Erk2, JNK2 or p38 together with either
an empty expression vector (–) or Myc-tagged
wild-type (Wt) or activated (Ac) Chp. Cell
extracts were used in an in vitro kinase assay
(upper panel) using the appropriate substrate
(myelin basic protein, GST–Jun and
GST–ATF2 respectively). Western blot
analysis (lower panel) with anti-HA and anti-
Myc antisera was performed to evaluate the
expression of the transfected kinases and
different Chp proteins. (b–d) Dominant-
negative (Dn) Chp blocks the activation of
JNK by Src, Cdc42Q61 and TNFα. HeLa
cells were cotransfected with plasmids
encoding Myc-tagged Chp Dn, HA-tagged
JNK2 and either Src or Cdc42Q61 as
indicated. To measure the effect of TNFα,
transfected cells were incubated for 15 min
with TNFα, lysed and subjected to the in vitro
kinase assay (as above).
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JNK pathway in HeLa cells (data not shown) and blocked
the activation of JNK by Src and by Cdc42Q61
(Figure 3b,c). A reduction in JNK activation by tumour
necrosis factor-α (TNFα) was also detected in cells trans-
fected with dominant-negative Chp (Figure 3d). As
described for Cdc42 and Rac GTPases [12,13], Chp did
not significantly activate Erk2 and failed to induce the
activation of the p38 kinase as well. These data suggest
that Chp, in contrast to Rac and Cdc42Hs, is a selective
activator of the JNK MAP kinase cascade but not of the
Erk or p38 pathways.
Chp is implicated in the induction of lamellipodia
To test whether Chp has a role in the control of the actin
cytoskeleton, we microinjected plasmids encoding acti-
vated Chp and stained for either Chp expression or poly-
merized actin. Chp was concentrated on one side of the
nucleus at the Golgi apparatus and colocalized with the
coatomer protein βCOP at the Golgi in the brefeldin-A-
sensitive compartment (data not shown). In addition,
injected cells exhibited morphological changes (Figure 4)
demonstrated by induction of lamellipodia. Interestingly,
the Chp mutant in which the carboxyl terminus had been
deleted failed to induce lamellipodia and Chp was not
localized to the Golgi (data not shown). These data further
support the role of the Chp carboxyl terminus in the local-
ization of Chp to the Golgi and in the induction of lamel-
lipodia, possibly through interaction with Pak2.
The data presented in this paper describe Chp as a new
Rho GTPase that interacts with Pak2, that is implicated in
the reorganization of the actin cytoskeleton and that acti-
vates the JNK pathway. Among the novel features of Chp
are the unique amino and carboxyl termini, which are not
found on any other known Rho-related GTPases and are
implicated in localizing Chp and the interaction of Chp
with Pak.
Supplementary material
Additional methodological details are published with this article on the
internet.
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Figure 4
The activated Chp mutant reorganizes the
cortical actin. Porcine endothelial cells were
microinjected with (a,b) a Myc-tagged Chp
expression vector or (c) a vector control
(50 ng/µl plasmid), fixed 4–6 hr after injection
and subsequently visualized by
immunofluorescence microscopy. Chp
localization in (a) was detected by staining
with FITC-tagged Myc antibody. Polymerized
actin was visualized in (b,c) by staining with
Texas-red-conjugated phalloidin.
Reorganization of the actin cytoskeleton can
be seen in (b) compared with (c).
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Materials and methods
Plasmids and constructs
For Chp expression vectors, mammalian expression vectors were
generated by fusing Chp cDNA in frame with cDNA encoding the
Myc epitope tag in the pCan mammalian expression vector. Yeast
expression vectors were generated by fusion of Chp cDNA in frame
with cDNA encoding the Src myristoylation signal in the pYes2
expression vector (Invitrogen Inc.). Plasmids encoding different
Cdc42 mutants were subcloned into the pYes2 expression vector
using standard procedures. Chp mutagenesis was performed using
the Chameleon mutagenesis kit (Stratagene Inc.) according to the
manufacturer’s instructions.
Northern blot analysis
Northern blots were purchased from Clontech Inc. and performed as
described in the manufacturer’s protocols. The specific probes were
generated by random primer labelling kit (Stratagene Inc.). Probes were
incubated with filters for 2 hr at 68°C. The filters were washed three
times with 2 × SSC containing 0.1% SDS at room temperature fol-
lowed by two washes with 0.1 × SSC containing 0.1% SDS at 55°C.
Western blot analysis
Protein extracts (50 µg/lane) were resolved on an SDS–12.5% poly-
acrylamide gel, blotted onto nitrocellulose membrane, and probed with
anti-Myc antibodies or affinity-purified Chp antibodies. Anti-mouse anti-
body or protein A conjugated to horseradish peroxidase were used in a
secondary incubation. The nitrocellulose blots were developed using
the SuperSignal chemiluminescent reaction kit (Promega Inc.).
Chp antibody was generated against the  carboxyl terminus peptide
216-KLNAKGVRTLSRCRWKK-232 conjugated to Keyhole-Limpet
haemocyanin (KLH). Antibody purification was carried out by coupling
10 mg of the peptide to 10 ml of agarose gel. The gel was equilibrated
with PBS and the crude serum was applied to the gel, washed and
antibody was eluted by glycine buffer pH 2.0.
Yeast manipulations
Conventional yeast transfection and manipulation protocols were used
as described [4,5].
Transfection and in vitro kinase assays
293 cells were transfected using the CaPO4 precipitation procedure.
Cells were cotransfected with pCan expression plasmids driving the
expression of different Chp mutants (5 µg) and Srα expression vectors
driving the expression of the different HA-tagged kinases (5 µg). 48 hr
following transfection, protein was extracted and in vitro kinase assays
were performed as described [7]. For HA–Erk2, HA–JNK2 and
HA–p38, the following purified substrates (5 µg/assay) were used
respectively: myelin basic protein (MBP), GST–c-Jun 1–79, and
GST–ATF2∆. 
To study the effect of Chp on the activation of the JNK pathway by Src
and Cdc42, we transfected HeLa cells with Chp Dn together with
either Src or the activated form of Cdc42Q61 and HA-tagged JNK2.
To study the effect of Chp Dn on JNK activation by TNFα, transfected
cells were treated for 15 min with 10 ng TNFα/ml of media followed by
in vitro kinase assay as described above.
Microinjections and immunofluorescence microscopy
Porcine endothelial (PAE) cells grown in DMEM medium containing
10% fetal bovine serum were plated on coverslips. Expression vectors
encoding Myc-tagged Chp proteins were diluted to a concentration of
50 ng/µl in injection buffer (5 mM glutamate, 130 mM KCl) and
microinjected into the nucleus of approximately 100 subconfluent PAE
cells. Injected cells were incubated for 4–6 hr at 37°C. Cells were
fixed in 4% formaldehyde in PBS for 10 min and permeabilized by
washing in PBS containing 0.1% Triton X-100. For localization
studies, cells were cotreated with anti-Myc monoclonal antibody and
rabbit anti-βCOP (a gift from Richard Khan) for 45 min. The coverslips
were then washed with PBS-TX and cotreated with FITC-conjugated
donkey anti-mouse and Texas-red-conjugated donkey anti-rabbit for
30 min. For morphology studies, cells were treated with a primary anti-
Myc monoclonal antibody and FITC donkey anti-mouse secondary
antibody. Coverslips were then washed in PBS-TX and treated for
10 min with Texas-red-conjugated phalloidin. Fluorescence
microscopy was carried out using a Zeiss Axiophot with appropriate
filters for fluorescence detection.
Overlay assay
Recombinant proteins (Pak2 and WASP) were separated on
SDS–PAGE followed by blotting to a polyvinylidene fluoride (PVDF)
membrane, washing, and blocking with PBS containing 1% BSA and
100 mM DTT. Recombinant Chp (2–5 µg) was preloaded with radiola-
belled [γ-P32]GTP and incubated for 5–8 min with the PVDF filter. The
filter was washed for 5 min and exposed to film for 2 hr. Recombinant
proteins (Chp mutants, Pak2 and WASP) were expressed as a
Glu–Glu-tagged protein and purified from Sf9 cells as previously
described [7].
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